<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1179</article-id><article-id pub-id-type="doi">10.15690/vramn1179</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>IMMUNOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ИММУНОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of lipids in the signaling mechanisms of toll-like receptors</article-title><trans-title-group xml:lang="ru"><trans-title>Роль липидов в механизмах сигнализации толл-подобных рецепторов</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5018-0271</contrib-id><contrib-id contrib-id-type="spin">3006-5614</contrib-id><name-alternatives><name xml:lang="en"><surname>Kytikovа</surname><given-names>O. Yu.</given-names></name><name xml:lang="ru"><surname>Кытикова</surname><given-names>О. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>kytikova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6058-201X</contrib-id><contrib-id contrib-id-type="spin">5888-6099</contrib-id><name-alternatives><name xml:lang="en"><surname>Novgorodtseva</surname><given-names>T. P.</given-names></name><name xml:lang="ru"><surname>Новгородцева</surname><given-names>Т. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Biology, Professor</p></bio><bio xml:lang="ru"><p>д.б.н., профессор</p></bio><email>nauka@niivl.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4130-8899</contrib-id><contrib-id contrib-id-type="spin">4997-3432</contrib-id><name-alternatives><name xml:lang="en"><surname>Denisenko</surname><given-names>Yu. K.</given-names></name><name xml:lang="ru"><surname>Денисенко</surname><given-names>Ю. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD in Biology</p></bio><bio xml:lang="ru"><p>д.б.н.</p></bio><email>karaman@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2492-3198</contrib-id><contrib-id contrib-id-type="spin">3446-4852</contrib-id><name-alternatives><name xml:lang="en"><surname>Antonyuk</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Антонюк</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>antonyukm@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6413-9840</contrib-id><contrib-id contrib-id-type="spin">7869-1692</contrib-id><name-alternatives><name xml:lang="en"><surname>Gvozdenko</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Гвозденко</surname><given-names>Т. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>vfdnz@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Far Eastern Scientific Center of Physiology and Pathology of Respiration</institution></aff><aff><institution xml:lang="ru">Дальневосточный научный центр физиологии и патологии дыхания</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>75</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>585</fpage><lpage>593</lpage><history><date date-type="received" iso-8601-date="2020-01-11"><day>11</day><month>01</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-08"><day>08</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Издательство "Педиатръ"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-02-05"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/1179">https://vestnikramn.spr-journal.ru/jour/article/view/1179</self-uri><abstract xml:lang="en"><p><italic>Toll-like receptors (TLRs) are important players in innate and adaptive immune responses involved in the initiation of the inflammatory process in response to the stimulating influence of endogenous (аllarmine) and exogenous ligands (pathogens viruses, bacteria, fungi). It has now become apparent that not only viral and bacterial infections but non-infectious inflammatory diseases are accompanied by the activation of inflammatory response systems and the development of chronic inflammation associated with disorders in the regulation of the TLRs system. In this regard, the ligand-independent activation of TLRs, which occurs with the participation of lipids, is actively studied. Their signalling functions of TLRs implemented in unique microdomains does membrane lipid rafts that coordinate many cellular processes. The ability to activate TLRs has been found for saturated fatty acids (SFAs), both exogenous and endogenous. On the other hand, TLRs can be inhibited by omega-3 polyunsaturated fatty acids (PUFAs), which can block the inflammatory process. The activation of TLRs triggers a signal cascade that induces the production of reactive oxygen and nitrogen species. The development of oxidative stress is accompanied by the formation of oxidized forms of phospholipids (Ox-PLs), which also induce the development of chronic inflammation. At the same time, Ox-PLs is characterized not only by pro-inflammatory but also anti-inflammatory activity, which necessitates in-depth studies of their role in the implementation of these processes. This review article discusses the mechanisms by which SFAs, PUFAs, and Ox-PLs modulate TLRs activation in lipid rafts. Research into the details of these mechanisms will contribute to the development of a strategy to reduce the risk of chronic diseases caused by inflammatory reactions mediated by TLRs.</italic></p></abstract><trans-abstract xml:lang="ru"><p><italic>Толл-подобные рецепторы (TLRs) являются важными участниками врожденных и адаптивных иммунных реакций, вовлеченных в инициацию воспалительного процесса в ответ на стимулирующее влияние эндогенных (аллармины) и экзогенных (патогены вирусов, бактерий, грибов) лигандов. В настоящее время стало очевидным, что не только вирусные и бактериальные инфекции, но и неинфекционные воспалительные заболевания сопровождаются активацией систем воспалительного ответа и развитием хронического воспаления, связанного с нарушениями в регуляции системы TLRs. В связи с этим активно изучается лиганд-независимая активация TLRs, которая происходит с участием липидов. Свои сигнальные функции TLRs реализуют в уникальных микродоменах цитоплазматической мембраны — липидных рафтах, координирующих множество клеточных процессов. Способность к активации TLRs обнаружена для насыщенных жирных кислот (SFAs), как экзогенных, так и эндогенных. С другой стороны, TLRs могут быть ингибированы омега-3-полиненасыщенными жирными кислотами (PUFAs), что способствует блокированию воспалительного процесса. В результате активации TLRs запускается сигнальный каскад, который индуцирует производство активных форм кислорода и азота. Развитие оксидативного стресса сопровождается образованием окисленных форм фосфолипидов (Ox-PLs), которые также индуцируют развитие хронического воспаления. В то же время для Ox-PLs характерна не только провоспалительная, но и противовоспалительная активность, что обусловливает необходимость проведения глубоких исследований их роли в реализации данных процессов. В представленной обзорной статье рассматриваются и обсуждаются механизмы, с помощью которых SFAs, PUFAs и Ox-PLs модулируют активацию TLRs в липидных рафтах. Проведение научных исследований по детализации этих механизмов будет способствовать разработке стратегии снижения риска хронических заболеваний, которые вызваны воспалительными реакциями, опосредованными TLRs.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>toll-like receptors</kwd><kwd>lipids</kwd><kwd>lipid rafts</kwd><kwd>oxidized phospholipids</kwd><kwd>saturated and polyunsaturated fatty acids</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>толл-подобные рецепторы</kwd><kwd>липиды</kwd><kwd>липидные рафты</kwd><kwd>окисленные фосфолипиды</kwd><kwd>насыщенные и полиненасыщенные жирные кислоты</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Государственное задание</institution></institution-wrap><institution-wrap><institution xml:lang="en">State task</institution></institution-wrap></funding-source></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hagar JA, Powell DA, Aachoui Y, et al. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science. 2013;341:1250–1253. doi: https://doi.org/10.1126/science.1240988</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Zakeri A, Russo M. Dual Role of Toll-like Receptors in Human and Experimental Asthma Models. Front Immunol. 2018;9:1027. doi: https://doi.org/10.3389/fimmu.2018.01027</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sallustio F, Curci C, Stasi A, et al. Role of Toll-Like Receptors in Actuating Stem/Progenitor Cell Repair Mechanisms: Different Functions in Different Cells. Stem Cells Int. 2019:6795845. doi: https://doi.org/10.1155/2019/6795845</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Kumar V. Toll-like receptors in the pathogenesis of neuroinflammation. J Neuroimmunol. 2019;332:16–30. doi: https://doi.org/10.1016/j.jneuroim.2019.03.012</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014;289(51):35237–35245. doi: https://doi.org/10.1074/jbc.R114.619304</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>De Nardo D. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine. 2015;74:181–189. doi: https://doi.org/10.1016/j.cyto.2015.02.025</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Scior T, Alexander C, Zaehringer U. Reviewing and identifying amino acids of human, murine, canine and equine TLR4/MD-2 Receptor complexes conferring endotoxic Innate Immunity Activation by LPS/Lipid A, or antagonistic Effects by Eritoran, in Contrast to Species-Dependent modulation by Lipid IVa. Comput Struct Biotechnol J. 2013;5:e201302012. doi: https://doi.org/10.5936/csbj.201302012</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hwang DH, Kim JA, Lee JY. Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Еur J Pharmacol. 2016;785:24–35. doi: https://doi.org/10.1016/j.ejphar.2016.04.024</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mirotti L, Alberca Custodio RW, Gomes E, et al. CpG-ODN shapes alum adjuvant activity signaling via MyD88 and IL-10. Front Immunol. 2017;8:47. doi: https://doi.org/10.3389/fimmu.2017.00047</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Сhristou EAA, Giardino G, Stefanaki E, Ladomenou F. Asthma: An Undermined State of Immunodeficiency. Int Rev Immunol. 2019;38(2):70–78. doi: https://doi.org/10.1080/08830185.2019.1588267</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635–645. doi: https://doi.org/10.1016/j.cmet.2012.04.001</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gong T, Yang Y, Jin T, et al. Orchestration of NLRP3 inflammasome activation by ion fluxes. Trends Immunol. 2018;39(5):393–406. doi: https://doi.org/10.1016/j.it.2018.01.009</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Frazao JB, Errante PR, Condino-Neto A. Toll-like receptors’ pathway disturbances are associated with increased susceptibility to infections in humans. Archivum Immunologiae et Therapiae Experimentalis. 2013;61(6):427–443. doi: https://doi.org/10.1007/s00005-013-0243-0</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bruchard M, Rebé C, Derangère V, et al. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol. 2015;16(8):859–870. doi: https://doi.org/10.1038/ni.3202</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Koppenol-Raab M, Sjoelund V, Manes NP, et al. Proteome and secretome analysis reveals differential post-transcriptional regulation of Toll-like receptor responses. Mol Cell Proteomics. 2017;16(4 Suppl 1):S172–S186. doi: https://doi.org/10.1074/mcp.M116.064261</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kleveta G, Borzęcka K, Zdioruk M, et al. LPS induces phosphorylation of actin-regulatory proteins leading to actin reassembly and macrophage motility. J Cell Biochem. 2012;113(1):80–92. doi: https://doi.org/10.1002/jcb.23330</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Plociennikowska A, Hromada‐Judycka A, Borzecka K, et al. Co‐operation of TLR4 and raft proteins in LPS‐induced pro‐inflammatory signaling. Cell Mol Life Sci. 2015;72(3):557–581. doi: https://doi.org/10.1007/s00018-014-1762-5</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schoeniger A, Fuhrmann H, Schumann J. LPS- or Pseudomonas aeruginosa-mediated activation of the macrophage TLR4 signaling cascade depends on membrane lipid composition. Peer J. 2016;4:e1663. doi: https://doi.org/10.7717/peerj.1663</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Engin AB. Adipocyte-Macrophage Cross-Talk in Obesity. Adv Exp Med Biol. 2017;960:327–343. doi: https://doi.org/10.1007/978-3-319-48382-5_14</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Arleevskaya MI, Larionova RV, Brooks WH, et al. Toll-Like Receptors, Infections, and Rheumatoid Arthritis. Clin Rev Allergy Immunol. 2020;58(2):172–181. doi: https://doi.org/10.1007/s12016-019-08742-z</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Varshney P, Yadav V, Saini N. Lipid rafts in immune signalling: current progress and future perspective. Immunology. 2016;149(1):13–24. doi: https://doi.org/10.1111/imm.12617</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ruysschaert JM, Lonez C. Role of lipid microdomains in TLR-mediated signalling. Biochim. Biophys. Acta. 2015;1848(9):1860–1867. doi: https://doi.org/10.1016/j.bbamem.2015.03.014</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Huang S, Rutkowsky JM, Snodgrass RG, et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res. 2012;53(9):2002–2013. doi: https://doi.org/10.1194/jlr.D029546</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Li Y, Deng SL, Lian ZX, et al. Roles of Toll-Like Receptors in Nitroxidative Stress in Mammals. Cells. 2019;8(6):pii:E576. doi: https://doi.org/10.3390/cells8060576</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Hellwing C, Tigistu-Sahle F, Fuhrmann H, et al. Lipid composition of membrane microdomains isolated detergent-free from PUFA supplemented RAW264.7 macrophages. Journal of Cellular Physiology. 2018;233(3):2602–2612. doi: https://doi.org/10.1002/jcp.26138</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Кытикова О.Ю., Антонюк М.В., Гвозденко Т.А., Новгородцева Т.П. Метаболические аспекты взаимосвязи ожирения и бронхиальной астмы // Ожирение и метаболизм. — 2018. — Т. 15. — № 4. — С. 9–14. [Kytikova OJu, Antonjuk MV, Gvozdenko TA, Novgorodceva TP. Metabolic aspects of the relationship of asthma and obesity. Ozhirenie i Metabolizm. 2018;15(4):9–14. (In Russ.)] doi: https://doi.org/10.14341/OMET9578</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Kytikova O, Novgorodtseva T, Antonyuk M, et al. Pro-resolving lipid mediators in the pathophysiology of asthma. Medicina. 2019;55(6):284. doi: https://doi.org/10.3390/medicina55060284</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Novgorodtseva TP, Gvozdenko TA, Vitkina TI, et al. Regulatory signal mechanisms of systemic inflammation in respiratory pathology. Russian Open Medical Journal. 2019;8(1):e0106. doi: https://doi.org/10.15275/rusomj.2019.0106</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Novgorodtseva TP, Denisenko YK, Zhukova NV, et al. Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases. Lipids in Health and Disease. 2013;12:117. doi: https://doi.org/10.1186/1476-511X-12-117</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Lydic TA, Goo Y-H. Lipidomics unveils the complexity of the lipidome in metabolic diseases. Clin Transl Med. 2018;7:4. doi: https://doi.org/10.1186/s40169-018-0182-9</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Diaz-Rohrer BB, Levental KR, Simons K, et al. Membrane raft association is a determinant of plasma membrane localization. Proc Natl Acad Sci USA. 2014;111:8500–8505. doi: https://doi.org/10.1073/pnas.1404582111</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Farnoud AM, Toledo AM, Konopka JB, et al. Raft-Like Membrane Domains in Pathogenic Microorganisms. Сurr Top Membr. 2015;75:233–268. doi: https://doi.org/10.1016/bs.ctm.2015.03.005</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Goñi FM. “Rafts”: A nickname for putative transient nanodomains. Chem Phys Lipids. 2019;218:34–39. doi: https://doi.org/10.1016/j.chemphyslip.2018.11.006</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Georgieva R, Chachaty C, Staneva G. Docosahexaenoic acid promotes micron scale liquid-ordered domains. A comparison study of docosahexaenoic versus oleic acid containing phosphatidylcholine in raft-like mixtures. Biochim. Biophys. Acta. 2015;1848:1424–1435. doi: https://doi.org/10.1016/j.bbamem.2015.02.027</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Tulodziecka K, Diaz-Rohrer BB, Farley MM, et al. Remodeling of the postsynaptic plasma membrane during neural development. Mol Biol Cell. 2016;27:3480–3489. doi: https://doi.org/10.1091/mbc.E16-06-0420</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Lorent JH, Diaz-Rohrer B, Lin X, et al. Structural determinants and functional consequences of protein affinity for membrane rafts. Nat. Commun. 2017;8:1219. doi: https://doi.org/10.1038/s41467-017-01328-3</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Sezgin E, Levental I, Mayor S, et al. The mystery of membrane organization: composition, regulation and physiological relevance of lipid rafts. Rev Mol Cell Biol. 2017;18(6):361–374. doi: https://doi.org/10.1038/nrm.2017.16</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Lee I-H, Imanaka MY, Modahl EH, Lipid AP. Raft Phase Modulation by Membrane-Anchored Proteins with Inherent Phase Separation Properties. Torres-Ocampo. ACS Omega. 2019;4(4):6551–6559. doi: https://doi.org/10.1021/acsomega.9b00327</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Kinoshita M. Raft-based sphingomyelin interactions revealed by new fluorescent sphingomyelin analogs. J Cell Biol. 2017;216:1183–1204. doi: https://doi.org/10.1083/jcb.201607086</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Hou TY, Barhoumi R, Fan Y-Y, Rivera GM, et al. n-3 polyunsaturated fatty acids suppress CD4(+) T cell proliferation by altering phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P-2] organization. Biochim Biophys Acta. 2016;1858(1):85–96. doi: https://doi.org/10.1016/j.bbamem.2015.10.009</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Sciacca MFM, Lolicato F, Di Mauro G, et al. The role of cholesterol in driving iapp-membrane interactions. Biophys J. 2016;111(1):140–151. doi: https://doi.org/10.1016/j.bpj.2016.05.050</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Biwer L, Isakson BE. Endoplasmic reticulum mediated signaling in cellular microdomains. Acta Physiol (Oxf). 2017;219(1):162–175. doi: https://doi.org/10.1111/apha.12675</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Bian X, Saheki Y, De Camilli P. Ca2+ releases E-Syt1 autoinhibition to couple ER-plasma membrane tethering with lipid transport. EMBO J. 2018;37(2):219–234. doi: https://doi.org/10.15252/embj.201797359</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Suzuki M. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation. 2010;122(19):1919–1927. doi: https://doi.org/10.1161/CIRCULATIONAHA.110.961193</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Zhu X. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res. 2010;51(11):3196–3206. doi: https://doi.org/10.1194/jlr.M006486</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Yvan-Charvet L. ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ Res. 2010;106(12):1861–1869. doi: https://doi.org/10.1161/CIRCRESAHA.110.217281</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Carroll RG, Zaslona Z, Galván-Peña S, et al. An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation. J Biol Chem. 2018;293(15):5509–5521. doi: https://doi.org/10.1074/jbc.RA118.001921</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Pinot M, Vanni S, Barelli H. Lipid cell biology. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins. Science. 2014;345:693–697. doi: https://doi.org/10.1126/science.1255288</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Frisz JF, Klitzing HA, Lou K, et al. Sphingolipid domains in the plasma membranes of fibroblasts are not enriched with cholesterol. J Biol Chem. 2013;288(23):16855–16861. doi: https://doi.org/10.1074/jbc.M113.473207</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Casares D, Escribá PV, Rosselló CA. Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues. Int J Mol Sci. 2019;20(9):2167. doi: https://doi.org/10.3390/ijms20092167</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018;19:281–296. doi: https://doi.org/10.1038/nrm.2017.138</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Kiefer K, Casas J, García-López R, Vicente R. Ceramide Imbalance and Impaired TLR4-Mediated Autophagy in BMDM of an ORMDL3-Overexpressing Mouse Model. Int J Mol Sci. 2019;20(6):1391. doi: https://doi.org/10.3390/ijms20061391</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Levental KR. Polyunsaturated lipids regulate membrane domain stability by tuning membrane order. Biophys J. 2016;110(8):1800–1810. doi: https://doi.org/10.1016/j.bpj.2016.03.012</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Shaikh SR, Kinnun JJ, Wassall SR. How polyunsaturated fatty acids modify molecular organization in membranes: insight from NMR studies of model systems. Biochim. Biophys. Acta. 2015;1848(1Pt.B):211–219. doi: https://doi.org/10.1016/j.bbamem.2014.04.020</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Prajapati B, Jena PK, Rajput P, et al. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes. Curr Diabetes Rev. 2014;10(3):190–200. doi: https://doi.org/10.2174/1573399810666140515112609</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Rocha DM, Caldas AP, Oliveira LL, et al. Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis. 2016;244:211–215. doi: https://doi.org/10.1016/j.atherosclerosis.2015.11.015</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Snodgrass RG, Huang S, Choi IW, et al. Inflammasome-mediated secretion of IL-1beta in human monocytes through TLR2 activation; modulation by dietary fatty acids. J Immunol. 2013;191:4337–4347. doi: https://doi.org/10.4049/jimmunol.1300298</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Kang JY, Lee JO. Structural biology of the Toll-like receptor family. Annu Rev Biochem. 2011;80:917–941. doi: https://doi.org/10.1146/annurev-biochem-052909-141507</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Wong SW, Kwon MJ, Choi AM, et al. Fatty acids modulate Toll‐like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species‐dependent manner. J Biol Chem. 2009;284:27384–27392. doi: https://doi.org/10.1074/jbc.M109.044065</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Kytikova OY, Novgorodtseva TP, Antonyuk MV, et al. Molecular targets of fatty acid ethanolamides in asthma. Medicina (Kaunas). 2019;55(4):87. doi: https://doi.org/10.3390/medicina55040087</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Wu M-Y, Li Ch-J, Hou M-F, et al. New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis. Int J Mol Sci. 2017;18(10):2034–2040. doi: https://doi.org/10.3390/ijms18102034</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>McCormick SPA, Schneider WJ. Lipoprotein(a) catabolism: a case of multiple receptors. Pathology. 2019;51(2):155–164. doi: https://doi.org/10.1016/j.pathol.2018.11.003</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Dana N, Vaseghi G, Haghjooy Javanmard S. Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review. Adv Pharm Bull. 2019;9(1):12–21. doi: https://doi.org/10.15171/apb.2019.003</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Walton KA, Cole AL, Yeh M, et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol. 2003;23:1197–1203. doi: https://doi.org/10.1161/01.ATV.0000079340.80744.B8</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Voelker DR, Numata M. Phospholipid regulation of innate immunity and respiratory viral infection. J Biol Chem. 2019;294(12):4282–4289. doi: https://doi.org/10.1074/jbc.AW118.003229</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Kandasamy P, Numata M, Zemski Berry K, et al. Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit Toll-like receptor 2 and 4 signaling. J. Lipid Res. 2016;57:993–1005. doi: https://doi.org/10.1194/jlr.M065201</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Bretscher P, Egger J, Shamshiev A, et al. Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2. EMBO Mol Med. 2015;7:593–607. doi: https://doi.org/10.15252/emmm.201404702</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Azzam KM, Fessler MB. Crosstalk between reverse cholesterol transport and innate immunity. Trends Endocrinol Metab. 2012;23:169–178. doi: https://doi.org/10.1016/j.tem.2012.02.001</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Erridge C, Kennedy S, Spickett CM, et al. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem. 2008;283:24748–24759. doi: https://doi.org/10.1074/jbc.M800352200</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Никонова А.А., Хаитов М.Р., Хаитов Р.М. Перспективы использования агонистов и антагонистов Toll-подобных рецепторов для профилактики и лечения вирусных инфекций // Медицинская иммунология. — 2019. — Т. 21.— № 3. — С. 937–406. [Nikonova AA, Khaitov MR, Khaitov RM. Perspektivy ispol’zovaniya agonistov i antagonistov dorozhnyye-podobnykh retseptorov dlya profilaktiki i lecheniya virusnykh infektsiy. Meditsinskaya Immunologiya. 2019;21(3):937–406. (In Russ.)] doi: https://doi.org/doi.org/10.15789/1563-0625-2019-3-397-40626</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Dowling JK, Mansell A. Toll-like receptors: the swiss army knife of immunity and vaccine development. Clin. Transl. Immunology. 2016;5(5):e85. doi: https://doi.org/10.1038/cti.2016.22</mixed-citation></ref></ref-list></back></article>
